{"id":"https://openalex.org/W2394925950","doi":"https://doi.org/10.1007/s40744-016-0033-3","title":"Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis","display_name":"Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis","publication_year":2016,"publication_date":"2016-05-25","ids":{"openalex":"https://openalex.org/W2394925950","doi":"https://doi.org/10.1007/s40744-016-0033-3","mag":"2394925950","pmid":"https://pubmed.ncbi.nlm.nih.gov/27747520","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4999583"},"language":"en","primary_location":{"id":"doi:10.1007/s40744-016-0033-3","doi":"https://doi.org/10.1007/s40744-016-0033-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40744-016-0033-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40744-016-0033-3.pdf","source":{"id":"https://openalex.org/S4210196954","display_name":"Rheumatology and Therapy","issn_l":"2198-6576","issn":["2198-6576","2198-6584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s40744-016-0033-3.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042337225","display_name":"Robert Morlock","orcid":"https://orcid.org/0000-0002-8723-2562","observed_orcids":["https://orcid.org/0000-0002-8723-2562"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Morlock","raw_affiliation_strings":["Ardea Biosciences, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ardea Biosciences, San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088279912","display_name":"Pierre Chevalier","orcid":"https://orcid.org/0000-0003-0217-2319","observed_orcids":["https://orcid.org/0000-0003-0217-2319"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Pierre Chevalier","raw_affiliation_strings":["IMS Health HEOR, Zaventem, Belgium. pchevalier@be.imshealth.com","IMS Health HEOR, Zaventem, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Health HEOR, Zaventem, Belgium. pchevalier@be.imshealth.com","institution_ids":[]},{"raw_affiliation_string":"IMS Health HEOR, Zaventem, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109294952","display_name":"Laura Horne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura Horne","raw_affiliation_strings":["AstraZeneca, Wilmington, DE, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Wilmington, DE, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074126079","display_name":"Javier Nuevo","orcid":"https://orcid.org/0000-0002-9365-6361","observed_orcids":["https://orcid.org/0000-0002-9365-6361"]},"institutions":[{"id":"https://openalex.org/I4210149424","display_name":"AstraZeneca (Spain)","ror":"https://ror.org/05qqrnb63","country_code":"ES","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210149424"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Nuevo","raw_affiliation_strings":["AstraZeneca, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Madrid, Spain","institution_ids":["https://openalex.org/I4210149424"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058566347","display_name":"Chris M. Storgard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris Storgard","raw_affiliation_strings":["Ardea Biosciences, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ardea Biosciences, San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085808155","display_name":"Lalitha Padmanabhan Aiyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lalitha Aiyer","raw_affiliation_strings":["Ardea Biosciences, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ardea Biosciences, San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111017026","display_name":"Dionne M. Hines","orcid":"https://orcid.org/0009-0002-7669-075X","observed_orcids":["https://orcid.org/0009-0002-7669-075X"]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dionne M. Hines","raw_affiliation_strings":["IMS Health HEOR, Fairfax, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Health HEOR, Fairfax, VA, USA","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075022481","display_name":"Xavier Ansolabehere","orcid":"https://orcid.org/0009-0007-4619-265X","observed_orcids":["https://orcid.org/0009-0007-4619-265X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xavier Ansolabehere","raw_affiliation_strings":["IMS Health HEOR, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IMS Health HEOR, Paris, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017487533","display_name":"Fredrik Nyberg","orcid":"https://orcid.org/0000-0003-0892-5668","observed_orcids":["https://orcid.org/0000-0003-0892-5668"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I881427289","display_name":"University of Gothenburg","ror":"https://ror.org/01tm6cn81","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Fredrik Nyberg","raw_affiliation_strings":["AstraZeneca, M\u00f6lndal, Sweden","Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden","institution_ids":["https://openalex.org/I881427289"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5088279912"],"corresponding_institution_ids":[],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":1.1178,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.77923892,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"3","issue":"1","first_page":"53","last_page":"75"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10084","display_name":"Musculoskeletal pain and rehabilitation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3612","display_name":"Physical Therapy, Sports Therapy and Rehabilitation"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gout","display_name":"gout","score":1.0},{"id":"https://openalex.org/keywords/disease-control","display_name":"disease control","score":0.8960000276565552},{"id":"https://openalex.org/keywords/urate-lowering-therapy","display_name":"urate-lowering therapy","score":0.8809999823570251},{"id":"https://openalex.org/keywords/health-resource-utilization","display_name":"health resource utilization","score":0.7940000295639038},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.9990000128746033},{"id":"https://openalex.org/keywords/serum-uric-acid","display_name":"serum uric acid","score":0.6949999928474426},{"id":"https://openalex.org/keywords/gout-flares","display_name":"gout flares","score":0.8949999809265137},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.828000009059906},{"id":"https://openalex.org/keywords/cross-national-comparison","display_name":"cross-national comparison","score":0.47200000286102295}],"concepts":[{"id":"https://openalex.org/C2780402116","wikidata":"https://www.wikidata.org/wiki/Q133087","display_name":"Gout","level":2,"score":0.9155668616294861},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8704681992530823},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.5869231224060059},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5100191235542297},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.49965882301330566},{"id":"https://openalex.org/C6964187","wikidata":"https://www.wikidata.org/wiki/Q659256","display_name":"Indirect costs","level":2,"score":0.492740660905838},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.4487329423427582},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4323575794696808},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4212007224559784},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.39673173427581787},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3787146508693695},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.0},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1007/s40744-016-0033-3","doi":"https://doi.org/10.1007/s40744-016-0033-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40744-016-0033-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40744-016-0033-3.pdf","source":{"id":"https://openalex.org/S4210196954","display_name":"Rheumatology and Therapy","issn_l":"2198-6576","issn":["2198-6576","2198-6584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4999583","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4999583","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatol Ther","raw_type":"Text"},{"id":"pmid:27747520","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27747520","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology and therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s40744-016-0033-3","doi":"https://doi.org/10.1007/s40744-016-0033-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40744-016-0033-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40744-016-0033-3.pdf","source":{"id":"https://openalex.org/S4210196954","display_name":"Rheumatology and Therapy","issn_l":"2198-6576","issn":["2198-6576","2198-6584"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2394925950.pdf","grobid_xml":"https://content.openalex.org/works/W2394925950.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W58609645","https://openalex.org/W1898573023","https://openalex.org/W1963764397","https://openalex.org/W1964439201","https://openalex.org/W1973295648","https://openalex.org/W1982508920","https://openalex.org/W1987339529","https://openalex.org/W1988234387","https://openalex.org/W2020347354","https://openalex.org/W2022967311","https://openalex.org/W2029668562","https://openalex.org/W2030072500","https://openalex.org/W2039907866","https://openalex.org/W2044955359","https://openalex.org/W2051705072","https://openalex.org/W2055166179","https://openalex.org/W2067732852","https://openalex.org/W2077804318","https://openalex.org/W2094998560","https://openalex.org/W2099748786","https://openalex.org/W2102557151","https://openalex.org/W2103854626","https://openalex.org/W2106983312","https://openalex.org/W2114856205","https://openalex.org/W2119244745","https://openalex.org/W2123621112","https://openalex.org/W2125348945","https://openalex.org/W2131274394","https://openalex.org/W2131879291","https://openalex.org/W2134049088","https://openalex.org/W2147575954","https://openalex.org/W2150169647","https://openalex.org/W2151809600","https://openalex.org/W2152327479","https://openalex.org/W2153881026","https://openalex.org/W2156131531","https://openalex.org/W2163153907","https://openalex.org/W2172545980","https://openalex.org/W2185421699","https://openalex.org/W2342917841","https://openalex.org/W4249178993"],"related_works":["https://openalex.org/W6939767314","https://openalex.org/W2905881988","https://openalex.org/W2418299240","https://openalex.org/W2995850759","https://openalex.org/W4200077713","https://openalex.org/W4399481203","https://openalex.org/W2773843880","https://openalex.org/W2952386253","https://openalex.org/W2092339860","https://openalex.org/W3111252201"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1],"present":[2],"study":[3,100,104],"aimed":[4],"to":[5,124,235],"assess":[6],"disease":[7,109,197,237],"control,":[8],"health":[9],"resource":[10],"utilization":[11],"(HRU),":[12],"and":[13,16,27,45,50,131,143,173,186,193,203,212,229,239,243],"healthcare":[14],"costs,":[15],"their":[17],"predictors":[18,141],"in":[19,90,134,149,164,209],"gout":[20,54,112,144],"patients":[21,55,177,221],"across":[22],"the":[23,34,91,98,103,125,135,150,191,210],"USA,":[24],"UK,":[25,192],"Germany,":[26,190],"France.":[28],"METHODS:":[29],"Data":[30],"were":[31,73,133,147,157],"extracted":[32],"from":[33],"PharMetrics":[35],"Plus":[36],"(USA),":[37],"Clinical":[38],"Practice":[39],"Research":[40],"Datalink-Hospital":[41],"Episode":[42],"Statistics":[43],"(UK),":[44],"Disease":[46],"Analyzer":[47],"databases":[48],"(Germany":[49],"France)":[51],"for":[52,65,81],"adult":[53],"over":[56],"a":[57],"3-year":[58],"period:":[59],"2009-2011":[60],"(all":[61],"dates":[62],"+1":[63],"year":[64,101],"France).":[66],"Patients":[67],"had":[68],"\"prevalent":[69],"established":[70],"gout\"":[71],"(i.e.,":[72],"treated":[74],"with":[75,94,127,160],"urate-lowering":[76,162,226],"therapy":[77],"[ULT]":[78],"or":[79,119],"eligible":[80],"ULT":[82],"based":[83],"on":[84],"American":[85],"College":[86],"of":[87,97,108,176,181,196],"Rheumatology":[88],"guidelines)":[89],"preindex":[92],"panel-year,":[93,138],"January":[95],"1":[96],"second":[99,136],"as":[102,219],"index":[105],"date.":[106],"Assessments":[107],"control":[110,182,198,238],"(uncontrolled":[111],"definition:":[113],"\u22651":[114],"serum":[115],"urate":[116],"(sUA)":[117],"elevation":[118],"\u22652":[120],"flares;":[121],"analysis":[122],"limited":[123],"subpopulation":[126],"sUA)":[128],"data,":[129],"HRU,":[130,205],"costs":[132,202],"post-index":[137,152],"while":[139,169],"potential":[140],"(demographics":[142],"treatment":[145,163,231],"characteristics)":[146],"identified":[148],"first":[151],"panel-year.":[153],"RESULTS:":[154],"Treatment":[155],"rates":[156],"high":[158,187],"(>70%":[159],"chronic":[161],"all":[165],"countries":[166],"but":[167],"France),":[168],"between":[170],"31.3%":[171],"(France)":[172],"62.9%":[174],"(USA)":[175],"remained":[178],"uncontrolled.":[179],"Predictors":[180],"included":[183],"female":[184],"gender":[185],"adherence.":[188],"In":[189],"France,":[194],"lack":[195],"predicted":[199],"increased":[200,204],"gout-attributed":[201,207],"both":[206],"(also":[208],"USA)":[211],"non-gout-attributed.":[213],"CONCLUSION:":[214],"Gout":[215],"management":[216],"remains":[217],"suboptimal,":[218],"many":[220],"remain":[222],"uncontrolled":[223],"despite":[224],"using":[225],"treatment.":[227],"Effective":[228],"convenient":[230],"options":[232],"are":[233],"needed":[234],"improve":[236],"minimize":[240],"additional":[241],"HRU":[242],"costs.":[244],"FUNDING:":[245],"AstraZeneca.":[246]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}